Analysing the Anticancer Properties of Pterostilbene Through Absorption, Distribution, Metabolism, and Excretion

Monisha Prasad1, Silambarasan Tamil Selvan1, Rajeshkumar Shanmugam2

  • 1Centre for Global Health Research, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Chennai, IND.

Cureus
|May 17, 2024
PubMed

Insights

Pterostilbene (PTS), a compound from grapes and blueberries, shows potential for liver cancer treatment. Computational studies reveal strong interactions with key proteins in the wingless/integrated (Wnt) pathway, suggesting therapeutic benefits.

Area of Science:

  • Biochemistry
  • Computational Chemistry
  • Oncology

Background:

  • Liver cancer remains a significant global health challenge.
  • The wingless/integrated (Wnt) signaling pathway plays a crucial role in liver cancer development and progression.
  • Natural compounds are increasingly explored for their therapeutic potential in cancer treatment.

Purpose of the Study:

  • To investigate the therapeutic potential of pterostilbene (PTS) against liver cancer.
  • To analyze the molecular interactions of PTS with key proteins in the Wnt signaling pathway.
  • To evaluate the pharmacokinetic properties of PTS using computational methods.

Main Methods:

  • Molecular docking simulations using AutoDock Vina.
  • Absorption, Distribution, Metabolism, and Excretion (ADME) studies.
  • Retrieval of PTS and protein structures from PubChem and Protein Data Bank, respectively.

Main Results:

  • PTS exhibited strong binding affinities with critical Wnt pathway proteins, including vimentin, GSK3-β, E-cadherin, IL-6, IL-1β, JNK, and Wnt.
  • Molecular docking revealed significant hydrogen bonds, hydrophobic, and electrostatic interactions between PTS and target proteins.
  • ADME analysis indicated favorable pharmacokinetic properties for PTS, including moderate solubility and permeability, with low interaction potential.

Conclusions:

  • Pterostilbene demonstrates significant potential as a therapeutic agent for liver cancer.
  • Further research into PTS's molecular mechanisms and clinical applications in liver cancer therapy is warranted.
  • Computational drug discovery methods are valuable for identifying natural compounds with anticancer properties.